UPC Analytics
DEEN
Übersicht · Eingereicht:

ACT_1613/2025

VARIANTS OF C-TYPE NATRIURETIC PEPTIDE

VerletzungHauptverletzungsklageMunich LDInfringement Action
  • 2025-06-02Nur prozessualproceduralInfringement Action

    Scheduling order by Munich Local Division (UPC_CFI_18/2025 and UPC_CFI_439/2025, 2 June 2025) setting dates for interim conference (9 January 2026, videoconference) and oral hearing (18 March 2026, Munich) in BioMarin's infringement action against Ascendis Pharma, with counterclaim for revocation. Both proceedings will proceed together; a technically qualified judge will be appointed.